Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:564109.
doi: 10.1155/2014/564109. Epub 2014 Jan 28.

The Assessment of Viability of M. Tuberculosis after Exposure to CPC Using Different Methods

Affiliations

The Assessment of Viability of M. Tuberculosis after Exposure to CPC Using Different Methods

Gomathi Sekar et al. Int J Bacteriol. 2014.

Abstract

Settings. National Institute for Research in Tuberculosis, Chennai. Objective. To assess the proportion of metabolically active cells of Mycobacterium tuberculosis after exposed to CPC using FDA-EB vital staining and viable counts on LJ medium. Mycolic acid content in M. tuberculosis after exposure to CPC was estimated using HPLC. Methods. Clinical isolates of M. tuberculosis and standard reference strain M. tuberculosis H37Rv were used for FDA-EB, viable count, and HPLC. Results. FDA/EB consistently stained 70-90% of log phase cells as green and the remaining cells as red-orange. After CPC treatment, 65-70% of the cells stained red-orange. The viability counts were comparable to 0-day controls. Synthesis of mycolic acids in mycobacteria was reduced when exposed to CPC using HPLC due to the decreased metabolic activity of the organisms. Conclusion. The cells are metabolically inactive during storage with CPC but these cells grew well on LJ medium after removal of CPC. The viability of M. tuberculosis was maintained in CPC with minimal reduction. Mycolic acid content was reduced if the cells of M. tuberculosis were treated with CPC for 7 days. All the above findings provide yet another evidence for the damage of cell wall of M. tuberculosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
FDA-EB staining using Fluorescence microscopy.
Figure 2
Figure 2
Determination of mycolic acid content of M. tuberculosis after exposure to P-CPC (H37RV).
Figure 3
Figure 3
Determination of mycolic acid content of M. tuberculosis after exposure to P-CPC (clinical isolate).

Similar articles

Cited by

References

    1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning and Financing. Geneva, Switzerland: WHO; 2006.
    1. World Health Organization, Stop TB Partnership. The Stop TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. Geneva, Switzerland: WHO; 2006.
    1. World Health Organization. The Global Plan to Stop TB, 2006–2015. Actions for life-towards a world free of tuberculosis. Geneva, Switzerland: WHO; 2006. - PubMed
    1. Islam S., Rahman F., Munshi S. K., Ahmed J., Kamal S. M. M., Noor R. Use of fluorescein diacetate (FDA) staining to detect viable Mycobacterium tuberculosis . Bangladesh Journal of Medical Science. 2012;11(4)
    1. Harada S., Numata N. Application of FDA/EB staining for the detection of viable or non-viable mycobacteria in clinical specimens. Kekkaku. 1992;67(2):113–117. - PubMed

LinkOut - more resources